Providence Capital Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-430
| Closed | -$36.1K | – | 195 |
|
|
2024
Q3 | $36.1K | Buy |
430
+1
| +0.2% | +$84 | 0.01% | 188 |
|
|
2024
Q2 | $29.5K | Buy |
429
+1
| +0.2% | +$69 | 0.01% | 186 |
|
|
2024
Q1 | $31.4K | Buy |
428
+1
| +0.2% | +$73 | 0.01% | 182 |
|
|
2023
Q4 | $34.6K | Buy |
427
+1
| +0.2% | +$81 | 0.01% | 184 |
|
|
2023
Q3 | $31.9K | Buy |
426
+2
| +0.5% | +$150 | 0.01% | 179 |
|
|
2023
Q2 | $32.8K | Buy |
424
+215
| +103% | +$16.6K | 0.01% | 169 |
|
|
2023
Q1 | $17.4K | Hold |
209
| – | – | ﹤0.01% | 190 |
|
|
2022
Q4 | $17.9K | Buy |
209
+1
| +0.5% | +$86 | ﹤0.01% | 178 |
|
|
2022
Q3 | $13K | Sell |
208
-9
| -4% | -$563 | ﹤0.01% | 204 |
|
|
2022
Q2 | $13K | Buy |
217
+102
| +89% | +$6.11K | ﹤0.01% | 197 |
|
|
2022
Q1 | $7K | Buy |
115
+1
| +0.9% | +$61 | ﹤0.01% | 254 |
|
|
2021
Q4 | $8K | Sell |
114
-1
| -0.9% | -$70 | ﹤0.01% | 237 |
|
|
2021
Q3 | $8K | Sell |
115
-63,199
| -100% | -$4.4M | ﹤0.01% | 230 |
|
|
2021
Q2 | $4.36M | Buy |
63,314
+2,591
| +4% | +$178K | 1.41% | 25 |
|
|
2021
Q1 | $3.93M | Buy |
60,723
+2,121
| +4% | +$137K | 1.43% | 28 |
|
|
2020
Q4 | $3.41M | Buy |
58,602
+11,700
| +25% | +$682K | 1.4% | 35 |
|
|
2020
Q3 | $2.96M | Buy |
46,902
+9,700
| +26% | +$613K | 1.56% | 26 |
|
|
2020
Q2 | $2.86M | Sell |
37,202
-9,398
| -20% | -$723K | 1.62% | 25 |
|
|
2020
Q1 | $3.48M | Buy |
46,600
+1,900
| +4% | +$142K | 2.1% | 10 |
|
|
2019
Q4 | $2.91M | Buy |
+44,700
| New | +$2.91M | 1.56% | 22 |
|
|
2019
Q3 | – | Sell |
-6
| Closed | – | – | 235 |
|
|
2019
Q2 | $0 | Buy |
+6
| New | – | ﹤0.01% | 271 |
|
|
2018
Q4 | – | Sell |
-40
| Closed | -$3K | – | 258 |
|
|
2018
Q3 | $3K | Hold |
40
| – | – | ﹤0.01% | 243 |
|
|
2018
Q2 | $3K | Sell |
40
-73
| -65% | -$5.48K | ﹤0.01% | 239 |
|
|
2018
Q1 | $9K | Hold |
113
| – | – | 0.01% | 184 |
|
|
2017
Q4 | $8K | Buy |
+113
| New | +$8K | 0.01% | 216 |
|